EP3089988A4 - Novel polypeptides - Google Patents

Novel polypeptides Download PDF

Info

Publication number: EP3089988A4
Authority: EP; European Patent Office
Prior art keywords: novel polypeptides; polypeptides; novel
Prior art date: 2014-01-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP14876711.4A

Other languages

German (de)

French (fr)

Other versions

EP3089988A1 (en

Inventor

Tamara Sandler

Orly Devary

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Two To Biotech Ltd

Original Assignee

Two To Biotech Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-01-02

Filing date

2014-12-30

Publication date

2017-08-02

2014-01-02 Priority claimed from US14/146,237 external-priority patent/US9296786B2/en

2014-12-30 Application filed by Two To Biotech Ltd filed Critical Two To Biotech Ltd

2016-11-09 Publication of EP3089988A1 publication Critical patent/EP3089988A1/en

2017-08-02 Publication of EP3089988A4 publication Critical patent/EP3089988A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Hematology (AREA)
Obesity (AREA)
Zoology (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP14876711.4A 2014-01-02 2014-12-30 Novel polypeptides Withdrawn EP3089988A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14/146,237 US9296786B2 (en)	2009-08-02	2014-01-02	Shortened secreted polypeptides
PCT/IL2014/051136 WO2015101984A1 (en)	2014-01-02	2014-12-30	Novel polypeptides

Publications (2)

Publication Number	Publication Date
EP3089988A1 EP3089988A1 (en)	2016-11-09
EP3089988A4 true EP3089988A4 (en)	2017-08-02

Family

ID=53493361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP14876711.4A Withdrawn EP3089988A4 (en)	2014-01-02	2014-12-30	Novel polypeptides

Country Status (8)

Country	Link
EP (1)	EP3089988A4 (en)
JP (1)	JP2017502675A (en)
CN (1)	CN105916874A (en)
AU (1)	AU2014374945A1 (en)
CA (1)	CA2935624A1 (en)
IL (1)	IL246533A0 (en)
SG (1)	SG11201605354WA (en)
WO (1)	WO2015101984A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN113943344B (en) *	2021-09-30	2024-03-15	吉林农业大学	High-activity memory improvement derivative peptide and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011016026A2 (en) *	2009-08-02	2011-02-10	Two To Biotech Ltd.	Novel proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8541367B2 (en) *	2009-03-12	2013-09-24	Landing Biotech, Inc.	Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
US9296786B2 (en) *	2009-08-02	2016-03-29	Two To Biotech Ltd.	Shortened secreted polypeptides

2014
- 2014-12-30 CN CN201480072200.6A patent/CN105916874A/en active Pending
- 2014-12-30 CA CA2935624A patent/CA2935624A1/en not_active Abandoned
- 2014-12-30 JP JP2016544556A patent/JP2017502675A/en active Pending
- 2014-12-30 AU AU2014374945A patent/AU2014374945A1/en not_active Abandoned
- 2014-12-30 EP EP14876711.4A patent/EP3089988A4/en not_active Withdrawn
- 2014-12-30 SG SG11201605354WA patent/SG11201605354WA/en unknown
- 2014-12-30 WO PCT/IL2014/051136 patent/WO2015101984A1/en not_active Ceased
2016
- 2016-06-29 IL IL246533A patent/IL246533A0/en unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011016026A2 (en) *	2009-08-02	2011-02-10	Two To Biotech Ltd.	Novel proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAN W ET AL: "Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity", BIOCHEMICAL JOURNAL, PORTLAND PRESS LTD, GB, vol. 357, no. 1, 1 January 2001 (2001-01-01), pages 127 - 135, XP002231615, ISSN: 0264-6021, DOI: 10.1042/0264-6021:3570127 *
See also references of WO2015101984A1 *

Also Published As

Publication number	Publication date
SG11201605354WA (en)	2016-07-28
EP3089988A1 (en)	2016-11-09
JP2017502675A (en)	2017-01-26
AU2014374945A1 (en)	2016-07-21
CA2935624A1 (en)	2015-07-09
WO2015101984A1 (en)	2015-07-09
CN105916874A (en)	2016-08-31
IL246533A0 (en)	2016-08-31

Publication	Publication Date	Title
EP3171299A4 (en)	2017-08-16	Multi-smartcard
EP3204975A4 (en)	2018-11-21	Sofc-conduction
EP3674314B8 (en)	2023-07-12	Apelin polypeptides
EP3129108A4 (en)	2018-01-31	Hoverboard
EP3228352A4 (en)	2017-11-29	Electro-stimulator
EP3147357A4 (en)	2017-12-13	Novel beta-galactosidase
EP3238557A4 (en)	2018-05-30	Babygrow
EP3166949A4 (en)	2018-04-11	Thienothiophene-isoindigo
EP3196912A4 (en)	2018-05-02	Switch
EP3185895A4 (en)	2018-01-10	Modified vip3 polypeptides
EP3128526A4 (en)	2017-04-05	Indicator-equipped switch
EP3089988A4 (en)	2017-08-02	Novel polypeptides
GB201419237D0 (en)	2014-12-10	Novel polypeptides
GB201410265D0 (en)	2014-07-23	Novel polypeptides
EP3199528A4 (en)	2018-02-28	Abscinazole
AU2014904871A0 (en)	2014-12-18	Materials
AU2014905285A0 (en)	2015-01-22	Gyrostabiliser Improvements
EP3110412A4 (en)	2017-10-25	4-benzylsulfonyl-2-butenenitrile
HK1234756A1 (en)	2018-02-23	Apelin polypeptides
AU2014905171A0 (en)	2015-01-22	GroundControl
AU2014904776A0 (en)	2014-12-11	Weldoze
AU2014904667A0 (en)	2014-12-04	Barrowmate
AU2014905168A0 (en)	2015-01-22	1a
AU2014904529A0 (en)	2014-11-27	Gulicurl
AU2014904208A0 (en)	2014-11-06	Glindawand

Legal Events

Date	Code	Title	Description
2016-10-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2016-11-09	17P	Request for examination filed	Effective date: 20160713
2016-11-09	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2016-11-09	AX	Request for extension of the european patent	Extension state: BA ME
2016-11-16	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 38/04 20060101ALI20161007BHEP Ipc: C07K 7/08 20060101AFI20161007BHEP
2016-11-16	RIN1	Information on inventor provided before grant (corrected)	Inventor name: SANDLER, TAMARA Inventor name: DEVARY, ORLY
2017-04-05	DAX	Request for extension of the european patent (deleted)
2017-08-02	A4	Supplementary search report drawn up and despatched	Effective date: 20170630
2017-08-02	RIC1	Information provided on ipc code assigned before grant	Ipc: C07K 14/52 20060101ALI20170626BHEP Ipc: A61K 38/00 20060101ALI20170626BHEP Ipc: C07K 14/47 20060101ALI20170626BHEP Ipc: C07K 7/08 20060101AFI20170626BHEP
2018-03-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2018-07-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2018-08-15	18D	Application deemed to be withdrawn	Effective date: 20180130